Healthcare companies will largely benefit from tax reform that lowers the statutory business tax rate to 20 from 35 but those in research intensive sectors such as biotechnology could end up with an unpleasant surprise at tax time That s because Congress is considering
Source: NASDAQ
Tax Reform Takes a Bite Out of Biotech Stocks
Published in Apple iMac and iPhones
More from Apple iMac and iPhonesMore posts in Apple iMac and iPhones »
- New iPad Pro in the fall could have Apple Silicon M2 chip, maybe not MagSafe
- Speck Presidio Folio for MagSafe review: Portable charging convenience
- Best deals Jan. 23: $20 Audio-Technica earphones, $12 SanDisk USB-C Flash Drive, more!
- Apple Car engineering manager departs for Meta role
- Fall of 2022 will be Apple's biggest ever, if rumors are correct
